248 results
8-K
EX-1.1
CYTK
Cytokinetics Inc
28 May 24
Other Events
4:01pm
of any nature or respect, or owes a fiduciary or similar duty to the Company, in connection with such transaction or the process leading thereto.
17
424B5
CYTK
Cytokinetics Inc
24 May 24
Prospectus supplement for primary offering
4:56pm
will describe in the prospectus supplement, naming the underwriter, dealer or agent and the nature of any such relationship.
We or selling securityholders may
424B5
CYTK
Cytokinetics Inc
22 May 24
Prospectus supplement for primary offering
4:55pm
and the nature of any such relationship.
We or selling securityholders may sell securities directly or through agents we designate from time to time. We
8-K
EX-99.1
CYTK
Cytokinetics Inc
22 May 24
Other Events
4:15pm
Mechanochemical P i ADP domain Pre-Powerstroke State Actin sliding Actin sliding Malik, et al. Science 2011; 1439-1443 Planelles-Herrero, et al. Nature
8-K
EX-10.1
CYTK
Cytokinetics Inc
16 May 24
Departure of Directors or Certain Officers
6:56pm
not constitute an employment contract. Nothing in the Plan or in the Offering will in any way alter the at will nature of a Participant’s employment
8-K
EX-10.1
wrh1l
2 Oct 23
Departure of Directors or Certain Officers
9:06pm
S-3ASR
EX-4.8
fy42eezupgkym1g0p
18 Nov 22
Automatic shelf registration
5:24pm
S-3ASR
r0wjzlhybzwyte88j
18 Nov 22
Automatic shelf registration
5:24pm
8-K
EX-4.1
e46l6gakc02e q8
6 Jul 22
Cytokinetics Announces Proposed Convertible Senior Notes Offering
4:31pm